International Surgical Sleep Society Supports Hyoid Suspension
AIRLIFT emerges as the most effective, FDA-Cleared system for managing obstructive sleep apnea.
After thoroughly reviewing clinical studies, the International Surgical Sleep Society (ISSS) has officially backed hyoid suspension as a safe and effective remedy in the comprehensive management of obstructive sleep apnea (OSA). This endorsement reinforces the treatment’s reliability based on several decades of compelling clinical evidence.
Hyoid Suspension Explained
Hyoid myotomy and suspension (HS), either performed alone or alongside other upper airway surgeries, are now seen as significant solutions for those suffering from symptomatic adult patients with mild to severe OSA. The findings indicate that these procedures effectively address tongue base or hypopharyngeal obstruction.
In a noteworthy multi-center study led by Van Tassel and colleagues, involving the AIRLIFT techniques on thirty-nine patients, a remarkable 76.9% achieved surgical success. They experienced an average reduction in the Apnea-Hypopnea Index (AHI) of about 69%, demonstrating the robustness of hyoid suspension as a treatment modality.
The AIRLIFT Advantage
The clinical advantages associated with hyoid suspension are now more attainable due to the innovations introduced by AIRLIFT®, utilizing the Encore System from Siesta Medical. This approach stands out for being less invasive, while promising a more controlled execution of hyoid suspension procedures.
Peter Martin, CEO of Siesta Medical, emphasized the unique advantages of the AIRLIFT system, especially for patients who have previously struggled with Continuous Positive Airway Pressure (CPAP) therapy or have experienced epiglottic collapse. AIRLIFT provides an accessible treatment solution without demanding further patient involvement.
Minimally Invasive and Effective
The AIRLIFT hyoid suspension technique stands out for its minimally invasive nature and high tolerance among patients. It is also noted for its cost-effectiveness compared to alternative stimulation implants. The procedure involves repositioning the hyoid bone and securing it with two tiny implants and sutures, allowing for the airway to improve its stability and reduce obstructions during sleep.
This innovative treatment also effectively prevents the collapse of the epiglottis by adjusting the hyoepiglottic ligament, reinforcing the lateral airway walls, and repositioning the tongue base forward. Patients who receive the AIRLIFT procedure as part of a comprehensive treatment strategy report a median improvement of 74% in their sleep apnea-related obstructions.
About Siesta Medical
Siesta Medical is a privately-held company that specializes in creating effective treatments for obstructive sleep apnea (OSA). Since its inception in 2009, the company has designed innovative solutions, including the AIRLIFT® procedure, the Encore™ System, and the Revolution™ Suture Passer. These tools are engineered to facilitate hyoid and tongue suspensions, optimize the implantation process, reduce intraoperative time, and ensure long-lasting success for patients.
Frequently Asked Questions
What is the AIRLIFT system?
The AIRLIFT system is an FDA-cleared hyoid suspension treatment for obstructive sleep apnea, designed to be less invasive and highly effective.
How effective is hyoid suspension for sleep apnea?
Studies indicate a surgical success rate of 76.9%, with significant AHI reductions in patients undergoing the procedure.
Who can benefit from hyoid suspension?
This treatment is ideal for patients with mild to severe obstructive sleep apnea, especially those who did not respond well to CPAP therapy.
What are the benefits of AIRLIFT?
AIRLIFT provides a minimally invasive solution, significantly improves airway stability, and offers cost-effective treatment compared to other options.
How does Siesta Medical contribute to sleep apnea treatments?
Siesta Medical focuses on developing effective medical devices and procedures like AIRLIFT to address obstructive sleep apnea while minimizing surgical invasiveness.
